1. Home
  2. ARBB vs CANF Comparison

ARBB vs CANF Comparison

Compare ARBB & CANF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ARB IOT Group Limited

ARBB

ARB IOT Group Limited

N/A

Current Price

$5.00

Market Cap

7.6M

Sector

Technology

ML Signal

N/A

Logo Can-Fite Biopharma Ltd Sponsored ADR (Israel)

CANF

Can-Fite Biopharma Ltd Sponsored ADR (Israel)

HOLD

Current Price

$3.35

Market Cap

6.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARBB
CANF
Founded
1997
1994
Country
Singapore
Israel
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.6M
6.7M
IPO Year
2022
2011

Fundamental Metrics

Financial Performance
Metric
ARBB
CANF
Price
$5.00
$3.35
Analyst Decision
Strong Buy
Buy
Analyst Count
1
2
Target Price
$20.00
$50.00
AVG Volume (30 Days)
2.5K
22.2K
Earning Date
05-12-2026
03-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$2,715,455.50
Revenue Next Year
$24.79
$101.06
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.71
$0.17
52 Week High
$13.89
$10.40

Technical Indicators

Market Signals
Indicator
ARBB
CANF
Relative Strength Index (RSI) 61.46 52.90
Support Level $3.97 $2.87
Resistance Level $5.11 $3.60
Average True Range (ATR) 0.27 0.15
MACD 0.06 0.01
Stochastic Oscillator 70.48 62.85

Price Performance

Historical Comparison
ARBB
CANF

About ARBB ARB IOT Group Limited

ARB IOT Group Ltd is a provider of complete solutions to the clients for the integration of Internet of Things (IoT) systems and devices from designing to project deployment. The company offers a wide range of IoT systems as well as provides customers with a substantial range of services such as system integration and system support services. It delivers solutions like designing, installation, testing and commissioning of various IoT systems and devices as well as integration of automated systems, including installation of wire and wireless and mechatronic works. The company operates in two reportable segments: (i) the provision of hardware and software of IoT solutions and (ii) Investment holding and others. The majority of revenue is generated from the IoT solutions segment.

About CANF Can-Fite Biopharma Ltd Sponsored ADR (Israel)

Can Fite Biopharma Ltd is a clinical-stage biopharmaceutical company. The company focuses on developing orally bioavailable small-molecule drugs targeting the A3 adenosine receptor for treating cancer, inflammatory diseases, liver disorders, and related conditions. It has a pipeline of proprietary drug candidates in Phase II and Phase III clinical development. The company's platform targets the A3 adenosine receptor (A3AR), which is more expressed in inflammatory and cancerous cells than in normal cells. Its pipeline drugs include Namodenoson, Piclidenoson, CF602, and Cannabinoids.

Share on Social Networks: